Matthews Catherine Z - Departments of Drug Metabolism, Merck Research Laboratories

基本信息

浏览量：10

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Randomized Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of MK-1088, a Novel Dual Adenosine Receptor Antagonist, in Healthy Adult Participants

Pranav Gupta,Manash Chatterjee,Yeonil Kim, Kathleen Deschamps, Lieselotte Lemoine,Kristien Van Dyck,Catherine Zhou Matthews,Sylvie Rottey,Aubrey Stoch,Eseng Lai

Investigational new drugsno. 5 (2024): 492-499

引用0浏览0WOS引用

Pharmacokinetic and Pharmacodynamic Assessments of Atogepant in Healthy Male Adults: Results from Phase 1 Studies

Ramesh Boinpally,Marleen Depré, Griet Van Lancker,Marissa F Dockendorf,Phung Bondiskey,Jean-Francois Denef,Tom Reynders,Catherine Zhou Matthews,K Chris Min,Jialin Xu,Joel M Trugman,Jan de Hoon

Cephalalgia reports（2023）

引用0浏览0引用

Atogepant is Not Associated with Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults

K. Chris Min,Walter K. Kraft,Phung Bondiskey,Francheska Colon-Gonzalez,Wen Liu,Jialin Xu,Deborah Panebianco,Lori Mixson,Marissa F. Dockendorf,Catherine Z. Matthews,Ramesh Boinpally

Clinical and translational science（2020）

引用27浏览0WOS引用

Multiple, Once-Daily, Oral Doses of 170 mg Atogepant for 28 Days are Safe and Well Tolerated With No Clinically Significant Effect on Alanine Aminotransferase in Healthy Adults

K. Min,W. K. Kraft, P. Bondiskey, F. Colon-Gonzalez,W. Liu,J. Xu,D. Panebianco, L. Mixson, M. F. Dockendorf,C. Z. Matthews,R. Boinpally

HEADACHE（2020）

引用1浏览0引用

Single and Multiple Doses of Ubrogepant Are Not Associated with a Clinically Significant Elevation of Alanine Aminotransferase in Healthy Adult Males (P1.10-014)

Phung Bondiskey,Wendy Ankrom, Lu Wen,Chi‐Chung Li,Catherine Z. Matthews,John Palcza,Deborah Panebianco,Tom Reynders, Sofie Mesens,John A. Wagner,Abhijeet Jakate,Eugene E. Marcantonio

Neurologyno. 15_supplement (2019)

引用0浏览0引用

Absorption, Metabolism and Excretion of [14c]omarigliptin, a Once-Weekly DPP-4 Inhibitor, in Humans

Shiyao Xu, Dan Tatosian, Ian McIntosh,Maria Caceres,Catherine Z. Matthews,Koppara Samuel,Diana Selverian, Sanjeev Kumar,Eunkyung Kauh

Xenobioticano. 6 (2017): 584-591

引用0浏览0引用

Pharmacokinetic and Pharmacodynamic Effects of Multiple-dose Administration of Omarigliptin, a Once-weekly Dipeptidyl Peptidase-4 Inhibitor, in Obese Participants with and Without Type 2 Diabetes Mellitus

Carol Addy,Daniel Tatosian,Xiaoli S. Glasgow,Isaias N. Gendrano,Eunkyung Kauh,Ashley Martucci,Amy O. Johnson-Levonas,Diana Selverian,Catherine Z. Matthews, Marie Gutierrez,John A. Wagner,S. Aubrey Stoch

Clinical therapeutics（2016）

引用19浏览0WOS引用

Absorption, Metabolism, and Excretion of [14c] Omarigliptin, A Once-Weekly Dpp-4 Inhibitor, in Humans

Shiyao Xu,Anya Kauh,Daniel Tatosian, Ian Mcintosh,Maria Caceres,Catherine Matthews,Jutta Miller, Sanjeev Kumar,Mark Wirth

DIABETES（2014）

引用14浏览0引用

The effects of simvastatin on the pharmacokinectics of sitagliptin

Michael Cerra,Wen-Lin Luo,Susie Xiujiang Li,Catherine Z. Matthews,Edward A O'Neill,John A. Wagner,S. Aubrey Stoch,Matt S. Anderson

Journal de la thérapeutique des populations et de la pharamcologie cliniqueno. 3 (2012)

引用7浏览0引用

Bioavailability and Short-Term Tolerability of Alendronate in Glucocorticoid-Treated Children

Meranda Nakhla,Andrew E. Denker,James D. Connor,Thomas O. Carpenter,Philip D. Walson,Arturo G. Porras,Catherine Z. Matthews,Patrick Larson,Amanda Freeman,John A. Wagner,Leanne M. Ward

Clinical Therapeutics（2011）

引用8浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn